Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma

Summary

This study is looking at how safe BHB810 is in adults with gastric and gastroesophageal adenocarcinoma (GEJ). The purpose of this study is also to look at: how well the study drug works, how the study drug moves into, through, and out of the body, and how your body reacts to the study drug. Participants will get an IV infusion of BHB810 every 2 weeks while on study treatment.

Timeline

Start

2026-07

Primary completion

2028-12

Completion

2028-12

Drugs

Indications